These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 9935077)
41. Hyperthermia enhances localization of 111In-labeled hapten to bifunctional antibody in human colon tumor xenografts. Gridley DS; Ewart KL; Cao JD; Stickney DR Cancer Res; 1991 Mar; 51(5):1515-20. PubMed ID: 1997192 [TBL] [Abstract][Full Text] [Related]
42. Carcinoembryonic antigen as a target for radioimmunotherapy of human medullary thyroid carcinoma: antibody processing, targeting, and experimental therapy with 131I and 90Y labeled MAbs. Stein R; Juweid M; Mattes MJ; Goldenberg DM Cancer Biother Radiopharm; 1999 Feb; 14(1):37-47. PubMed ID: 10850286 [TBL] [Abstract][Full Text] [Related]
43. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re. Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657 [TBL] [Abstract][Full Text] [Related]
44. [Experimental study for the targeting therapy of mouse lung carcinoma treated by anti-hnRNPB1 monoclonal antibody with 131I]. Chen MY; Li WM; Xu D; Chen WB Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):766-9. PubMed ID: 17953353 [TBL] [Abstract][Full Text] [Related]
45. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct. Pavlinkova G; Booth BJ; Batra SK; Colcher D Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640 [TBL] [Abstract][Full Text] [Related]
46. Fractionated locoregional low-dose radioimmunotherapy improves survival in a mouse model of diffuse-type gastric cancer using a 213Bi-conjugated monoclonal antibody. Bloechl S; Beck R; Seidl C; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7070s-7074s. PubMed ID: 16203804 [TBL] [Abstract][Full Text] [Related]
47. Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies. Behr TM; Sharkey RM; Juweid ME; Dunn RM; Ying Z; Zhang CH; Siegel JA; Goldenberg DM J Nucl Med; 1997 Mar; 38(3):409-18. PubMed ID: 9074529 [TBL] [Abstract][Full Text] [Related]
48. [Influence of combination of low dosage 131I-labeled anti-carcinoembryonic antigen antibody C50 and 5-fluorouracil on tumor growth of colorectal cancer xenografts in nude mice]. Zheng CX; Zhan WH; Cai SR; He YL; Lin ZJ Ai Zheng; 2003 Apr; 22(4):354-7. PubMed ID: 12703987 [TBL] [Abstract][Full Text] [Related]
49. Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen. Sharkey RM; Pykett MJ; Siegel JA; Alger EA; Primus FJ; Goldenberg DM Cancer Res; 1987 Nov; 47(21):5672-7. PubMed ID: 3664474 [TBL] [Abstract][Full Text] [Related]